Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer.

Literature DB >> 25403579

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer.

M Alsina¹, S Landolfi², C Aura³, K Caci⁴, J Jimenez³, L Prudkin³, S Castro⁵, D Moreno³, B Navalpotro⁶, J Tabernero⁷, M Scaltriti⁸.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25403579 DOI： 10.1093/annonc/mdu535

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1^- mantle cell lymphoma.

Authors: David Martín-Garcia; Alba Navarro; Rafael Valdés-Mas; Guillem Clot; Jesús Gutiérrez-Abril; Miriam Prieto; Inmaculada Ribera-Cortada; Renata Woroniecka; Grzegorz Rymkiewicz; Susanne Bens; Laurence de Leval; Andreas Rosenwald; Judith A Ferry; Eric D Hsi; Kai Fu; Jan Delabie; Dennis Weisenburger; Daphne de Jong; Fina Climent; Sheila J O'Connor; Steven H Swerdlow; David Torrents; Sergi Beltran; Blanca Espinet; Blanca González-Farré; Luis Veloza; Dolors Costa; Estella Matutes; Reiner Siebert; German Ott; Leticia Quintanilla-Martinez; Elaine S Jaffe; Carlos López-Otín; Itziar Salaverria; Xose S Puente; Elias Campo; Sílvia Beà
Journal: Blood Date: 2018-12-11 Impact factor: 22.113

2. Continuously sutured versus linear-stapled anastomosis in robot-assisted hybrid Ivor Lewis esophageal surgery following neoadjuvant chemoradiotherapy: a single-center cohort study.

Authors: Fiorenzo V Angehrn; Kerstin J Neuschütz; Daniel C Steinemann; Martin Bolli; Lana Fourie; Pauline Becker; Markus von Flüe
Journal: Surg Endosc Date: 2022-07-19 Impact factor: 3.453

Review 3. Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.

Authors: Shuyang Yao; Funda Meric-Bernstam; David Hong; Filip Janku; Aung Naing; Sarina Anne Piha-Paul; Apostolia Maria Tsimberidou; Daniel Karp; Vivek Subbiah; Timothy Anthony Yap; Jordi Rodon Ahnert; Shubham Pant; Ecaterina E Ileana Dumbrava; Chetna Wathoo; Erick Campbell; Lihou Yu; Yuko Yamamura; Siqing Fu
Journal: Sci Rep Date: 2022-05-24 Impact factor: 4.996

4. Lower expression of PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) association with poor prognosis of gastric cancer.

Authors: Yachao Hou; Jingyu Deng; Li Zhang; Xingming Xie; Xiaofan Guo; Changyu Sun; Rupeng Zhang; Han Liang
Journal: Int J Clin Exp Med Date: 2015-11-15

Review 5. Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry.

Authors: Zbigniew Darzynkiewicz; Hong Zhao; Sufang Zhang; Marietta Y W T Lee; Ernest Y C Lee; Zhongtao Zhang
Journal: Oncotarget Date: 2015-05-20

6. Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.

Authors: Liang-Yu Bie; Dan Li; Yu Mu; Sheng Wang; Bei-Bei Chen; Hui-Fang Lyu; Li-Li Han; Cai-Yun Nie; Chang-Cheng Yang; Lin Wang; Chuan-Chuan Ren; Wei-Jie Zhang; Ping Guo; Feng Shi; Qing-Xia Fan; Liu-Xing Wang; Xiao-Bing Chen; Su-Xia Luo
Journal: Chronic Dis Transl Med Date: 2018-10-23

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer.

1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1^- mantle cell lymphoma.

2. Continuously sutured versus linear-stapled anastomosis in robot-assisted hybrid Ivor Lewis esophageal surgery following neoadjuvant chemoradiotherapy: a single-center cohort study.

Review 3. Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.

4. Lower expression of PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) association with poor prognosis of gastric cancer.

Review 5. Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry.

6. Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.

7. Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.

Review 8. Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.

9. NF-Y subunits overexpression in gastric adenocarcinomas (STAD).

Review 10. Novel Molecular Markers for Breast Cancer.

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer.

1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma.

2. Continuously sutured versus linear-stapled anastomosis in robot-assisted hybrid Ivor Lewis esophageal surgery following neoadjuvant chemoradiotherapy: a single-center cohort study.

Review 3. Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences.

4. Lower expression of PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) association with poor prognosis of gastric cancer.

Review 5. Initiation and termination of DNA replication during S phase in relation to cyclins D1, E and A, p21WAF1, Cdt1 and the p12 subunit of DNA polymerase δ revealed in individual cells by cytometry.

6. Analysis of cyclin E co-expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer.

7. Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling.

Review 8. Understanding Retinoblastoma Post-Translational Regulation for the Design of Targeted Cancer Therapies.

9. NF-Y subunits overexpression in gastric adenocarcinomas (STAD).

Review 10. Novel Molecular Markers for Breast Cancer.

1. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1^- mantle cell lymphoma.